insights_auto
Why is 1AE up 3,51%?
Dive Deeperchevron_right
1AE:ETR
argenx SE
730,40 €
arrow_upward
+3,51%(+24,80) 1D
9 ოქტ, 17:35:46 GMT+2 · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for 1AE...
Open
738,00 €
High
741,20 €
Low
721,40 €
Mkt. cap
43,80 მლრდ.
Avg. vol.
78,00
Volume
221,00
P/E ratio
31,07
52-wk high
922,00 €
52-wk low
574,20 €
EPS
23,51 €
No. of employees
2 ათ.
Open
738,00 €
High
741,20 €
Low
721,40 €
Mkt. cap
43,80 მლრდ.
Avg. vol.
78,00
Volume
221,00
P/E ratio
31,07
52-wk high
922,00 €
52-wk low
574,20 €
EPS
23,51 €
No. of employees
2 ათ.
News stories
From web sources and news partners
Simply Wall Street
·
14 საათის წინ
Could A Halted Sjögren Trial Alter The Investment Case For argenx Stock?
Yahoo Finance
·
19 საათის წინ
argenx (ENXTBR:ARGX) Stock May Be Fully Priced After Its 185% Run
AD HOC NEWS
·
1 დღის წინ
Argenx stock at EUR 724.80, market value USD 50.7 billion
Investing.com
·
1 დღის წინ
H.C. Wainwright reiterates argenx stock buy rating on celiac drug data
Profile
Argenx SE is a Belgian-Dutch pharmaceutical company specializing in immunology. Argenx specializes in the development of antibody therapies for the treatment of autoimmune diseases and cancer. Its work primarily focuses on the development of orphan drugs. Wikipedia
About argenx SE